NCT03350009

Unknown

Markers in Follicular Fluid and in Embryo Culture Medium as ...

Carmel Medical Center Source

Compare

Other study identifiers

Sponsor study identifier

CMC-16-0163-CTIL

Study Type

observational

Estimated enrollment

220

Locations

1 country

Sites

1

Timeline

Study Start

December 11, 2017

Actual (reported)

Primary Completion

June 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

November 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

Assessment of the quality of follicular fluid and early embryo via chemical markers.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 220 participants
Study completion date: November 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
November 2, 2017
Actual (reported)
First Posted
November 22, 2017
Actual (reported)
Study Start
December 11, 2017
Actual (reported)
Primary Completion
June 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: January 31, 2019
Status Verified: January 2019
Last Update Submitted: January 30, 2019

Conditions

Infertility/Sterility

Outcome Measures

Primary Outcomes (1)

Different markers discriminating the studied groups.
High correlation between the studied markers and the currently used morphological assessment of the quality of embryos and oocytes will define the potential of the studied markers as a mean for embryo and quality assessment. The current study is pioneer in the field of assessment of embryos and follicles and this group of markers have not been studied previously, therefore we prefer not to clarify more details
two years

Study Arms (2)

High and low grade embryos

The distribution for the high and low grade embryos is based on common morphological grading criteria.

High and low quality follicles

The distribution for the high and low grade oocytes is based on common morphological grading criteria and on different features of the participants such as age.

Eligibility Criteria

Age18 Years - 45 Years

Sexfemale(Gender-based eligibility)

Gender Eligibility DetailsParticipants are female patients undergoing IVF procedure in the IVF department in Carmel MC

Healthy VolunteersYes

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

Patients undergoing IVF procedures at Carmel Medical Center

You may qualify if:

Sponsors & Collaborators

Carmel Medical Center
Otherlead

Study Sites (1)

Carmel Medical Center

Haifa, 34362, Israel

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

Martha Direnfeld, Prof.
Carmel Medical Center
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: OTHER
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

November 2, 2017

First Posted

November 22, 2017

Study Start

December 11, 2017

Actual (reported)

Primary Completion

June 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Patients undergoing IVF procedures at Carmel Medical Center and are able to sign an informed consent form.

Female patients age 18-45

You may not qualify if:

Women with any malignancy
Patient's request to be withdrawn from the study.

Contact the study team to confirm eligibility.

Study Completion

November 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

January 31, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03350009
Data provider: ClinicalTrials.gov
Source updated: 2019-01-31
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:57 UTC

Locations

IL(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

High and low grade embryos

High and low quality follicles

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations